Clinical trial
Study of a Pandemic Influenza Vaccine in Elderly Participants
NCT00376402 · Seqirus, Industry · Completed
Key facts
| NCT number | NCT00376402 |
|---|---|
| Title | Study of a Pandemic Influenza Vaccine in Elderly Participants |
| Official title | Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants |
| Lead sponsor | Seqirus, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | H5N1 Pandemic Influenza Vaccine |
| Enrollment | 200 |
| Start date | Oct 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 14, 2006 |
| Last update posted | Jul 19, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: